The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic. The next call is July 9 from 2:30-3:45 p.m. ET. Food and Drug Administration Commissioner Stephen Hahn, M.D., will address FDA’s response to the COVID-19 epidemic, including emergency use authorizations, remdesivir distribution and vaccine clinical trials. 

In addition, AHA Board Chair Melinda Estes, M.D., AHA President and CEO Rick Pollack and AHA senior leaders will give updates on advocacy, regulatory and policy developments, as well as the association’s efforts to support members in their efforts to combat COVID-19. 

Callers are encouraged to dial in at least 10-15 minutes in advance. Please dial 800-469-8538 and enter the participant passcode 43576#.

Related News Articles

Headline
Respiratory illness activity remains high across the country, according to the latest data from the Centers for Disease Control and Prevention. Seasonal flu…
Headline
The Occupational Safety and Health Administration Jan. 13 announced that it terminated efforts to establish a final COVID-19 safety standard to protect workers…
Headline
The Department of Health and Human Services Dec. 10 amended the Public Readiness and Emergency Preparedness Act declaration for COVID-19, extending liability…
Headline
AHA's latest social media toolkit for encouraging vaccination against the flu and COVID-19 provides fall-themed social media posts and graphics. Download the…
Headline
The Centers for Disease Control and Prevention last week endorsed a recommendation for people aged 65 and older and for immunocompromised individuals to…
Headline
The Centers for Medicare & Medicaid Services Oct. 22 released final guidance detailing reporting requirements for the hospital respiratory data condition…